CHRISTIE GANNON: Open Payments
NPI 1487361416 · EL DORADO, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 16 payments from 7 companies in 2025. Trend: 2023 $251 · 2024 $416 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $266 |
| Novo Nordisk Inc | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $92 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $14 |
Products named: BREZTRI, Wegovy, Kerendia, FARXIGA, TRELEGY ELLIPTA, GEMTESA, Auvelity, AIRSUPRA.
Industry payments across KS — which companies pay providers there.
